deltatrials
Completed OBSERVATIONAL NCT01246778

Sunitinib and Atrial Trabeculae Contractility (SCAR)

The Influence of Sunitinib on Contractility of Human Atrial Trabeculae

Sponsor: Radboud University Medical Center

Conditions Cardiotoxicity Heart Failure Ischemia
Updated 12 times since 2017 Last updated: Apr 30, 2014 Started: Nov 30, 2010 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01246778, this observational or N/A phase trial focuses on Cardiotoxicity and Heart Failure and remains completed. Sponsored by Radboud University Medical Center, it has been updated 12 times since 2010, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Study Description(click to expand)

Study population: 44 (+22) patients undergoing CABG cardiac surgery with extracorporal circulation Intervention (if applicable): none (pharmacological interventions will only be performed ex-vivo in isolated atrial tissue) Main study parameters/endpoints The developed force in ex vivo atrial trabeculas during standardized stimulation.

Study population: 44 (+22) patients undergoing CABG cardiac surgery with extracorporal circulation Intervention (if applicable): none (pharmacological interventions will only be performed ex-vivo in isolated atrial tissue) Main study parameters/endpoints The developed force in ex vivo atrial trabeculas during standardized stimulation.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotCompleted~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshotCompleted~Apr 2018 – ~May 2018 · 30 days · monthly snapshotCompleted~May 2018 – ~Jun 2018 · 31 days · monthly snapshotCompleted~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshotCompleted~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted~Jan 2026 – present · 3 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed

  2. Sep 2024 — Present [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Mar 2022 — Jul 2024 [monthly]

    Completed

  5. Dec 2021 — Mar 2022 [monthly]

    Completed

▶ Show 7 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Jun 2018 — Nov 2020 [monthly]

    Completed

  4. May 2018 — Jun 2018 [monthly]

    Completed

  5. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  6. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  7. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Radboud University Medical Center
Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations